<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kagamu H</submitter><funding>Japan Agency for Medical Research and Development</funding><funding>Japan Society for the Promotion of Science</funding><pagination>4641-4653</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9755963</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>82(24)</volume><pubmed_abstract>CD4+ T-cell immunity helps clonal proliferation, migration, and cancer cell killing activity of CD8+ T cells and is essential in antitumor immune responses. To identify CD4+ T-cell clusters responsible for antitumor immunity, we simultaneously analyzed the naïve-effector state, Th polarization, and T-cell receptor clonotype based on single-cell RNA-sequencing data. Unsupervised clustering analysis uncovered the presence of a new CD4+ T-cell metacluster in the CD62Llow CD4+ T-cell subpopulation, which contained multicellular clonotypes associated with efficacy of programmed death-ligand 1 (PD-1) blockade therapy. The CD4+ T-cell metacluster consisted of CXCR3+CCR4-CCR6+ and CXCR3-CCR4-CCR6+ cells and was characterized by high expression of IL7 receptor and TCF7. The frequency of these cells</pubmed_abstract><journal>Cancer research</journal><pubmed_title>Single-Cell Analysis Reveals a CD4+ T-cell Cluster That Correlates with PD-1 Blockade Efficacy.</pubmed_title><pmcid>PMC9755963</pmcid><funding_grant_id>19ae0101074h0001</funding_grant_id><funding_grant_id>17H04184</funding_grant_id><pubmed_authors>Kagamu H</pubmed_authors><pubmed_authors>Yamasaki S</pubmed_authors><pubmed_authors>Mouri A</pubmed_authors><pubmed_authors>Imai H</pubmed_authors><pubmed_authors>Kanai Y</pubmed_authors><pubmed_authors>Kobayashi K</pubmed_authors><pubmed_authors>Yamaguchi O</pubmed_authors><pubmed_authors>Miura Y</pubmed_authors><pubmed_authors>Shibata T</pubmed_authors><pubmed_authors>Shiono A</pubmed_authors><pubmed_authors>Kaira K</pubmed_authors><pubmed_authors>Kitano S</pubmed_authors><pubmed_authors>Hashimoto K</pubmed_authors><pubmed_authors>Horimoto K</pubmed_authors><pubmed_authors>Nishihara F</pubmed_authors></additional><is_claimable>false</is_claimable><name>Single-Cell Analysis Reveals a CD4+ T-cell Cluster That Correlates with PD-1 Blockade Efficacy.</name><description>CD4+ T-cell immunity helps clonal proliferation, migration, and cancer cell killing activity of CD8+ T cells and is essential in antitumor immune responses. To identify CD4+ T-cell clusters responsible for antitumor immunity, we simultaneously analyzed the naïve-effector state, Th polarization, and T-cell receptor clonotype based on single-cell RNA-sequencing data. Unsupervised clustering analysis uncovered the presence of a new CD4+ T-cell metacluster in the CD62Llow CD4+ T-cell subpopulation, which contained multicellular clonotypes associated with efficacy of programmed death-ligand 1 (PD-1) blockade therapy. The CD4+ T-cell metacluster consisted of CXCR3+CCR4-CCR6+ and CXCR3-CCR4-CCR6+ cells and was characterized by high expression of IL7 receptor and TCF7. The frequency of these cells</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Dec</publication><modification>2026-07-14T21:12:14.1Z</modification><creation>2025-04-06T14:10:18.263Z</creation></dates><accession>S-EPMC9755963</accession><cross_references><pubmed>36219677</pubmed><doi>10.1158/0008-5472.CAN-22-0112</doi></cross_references></HashMap>